scholarly journals Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Daniel Satgé ◽  
Emmanuelle Kempf ◽  
Jean-Bernard Dubois ◽  
Motoi Nishi ◽  
Jean Trédaniel
Keyword(s):  
Lung Cancer ◽  
General Population ◽  
Treatment Plan ◽  
Tobacco Consumption ◽  
Epidemiological Studies ◽  
Strongly Correlated ◽  
Incidence And Mortality ◽  
Severe Impairment ◽  
Communication Impairments ◽  
Risk Of Cancer

As the life expectancy of people with intellectual disability (ID) has progressed, they have become similarly at risk of cancer as individuals of the general population. Epidemiological studies indicate a reduced incidence and mortality from lung cancer in the total population of persons with ID. However, the pattern is heterogeneous and the risk is strongly correlated with the impairment level; persons with mild intellectual impairment have higher cancer risk, and this subgroup also has the highest tobacco consumption (the major risk factor for lung cancer) compared to individuals with more severe impairment. Clinical presentation of lung cancer in persons with ID is often atypical, with symptoms frequently hidden by the mental state and communication impairments. Treatment can be impeded by incomplete understanding and lack of cooperation on the part of the patient; nevertheless, general principles for treating lung cancer must be applied to persons with ID. Early diagnosis and implementation of an adapted treatment plan may result in lung cancer outcomes similar to those of individuals in the general population. Physicians facing the difficult task of treating lung cancer in persons with ID are called to carry out their mission of care in a responsible, free, and creative way.

scholarly journals Trends in Lung Cancer and Smoking Behavior in Italy: An Alarm Bell for Women

2017 ◽  
Vol 103 (6) ◽  
pp. 543-550 ◽  
Author(s):  
Annalisa Trama ◽  
Roberto Boffi ◽  
Paolo Contiero ◽  
Carlotta Buzzoni ◽  
Roberta Pacifici ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Survival ◽  
Smoking Behavior ◽  
Cancer Control ◽  
Lung Cancer Mortality ◽  
Tobacco Consumption ◽  
Mortality Trends ◽  
Incidence And Mortality ◽  
Key Driver ◽  
The 1960S

Introduction The epidemiology of lung cancer is changing worldwide, with smoking being the key driver of lung cancer incidence and mortality. Our aim is to analyze the incidence, survival and mortality trends in Italy in the framework of the 2017 survey on smoking behavior in Italy. Methods AIRTUM 2017 reports on cancer survival and incidence; 2017 survey on smoking behavior in Italy. Results Men achieved progress in lung cancer control characterized by a decrease in incidence and mortality and an increase in survival. The decreasing use of tobacco in men (from 60% in the 1960s to 24% in 2017) was most likely responsible for the decreasing incidence and mortality. Women showed no progress: although survival improved slightly, the incidence and mortality were both on the rise. This was most likely due to the increasing smoking rates in women in the 1970s and 80s. Of major concern is the accelerated rise in the number of smoking women from 4.6 million in 2016 to 5.7 million in 2017 compared to the decrease observed in men (from 6.9 to 6 million). Conclusions The incidence and mortality trends in males clearly demonstrate that primary prevention is the most effective way to reduce lung cancer mortality. By contrast, a 24% increase in the prevalence of smoking among women in just 1 year is extremely worrying for the future, and calls for immediate action by targeted strategies to reduce tobacco consumption in women and avert the dreadful prospect of a lung cancer epidemic in Italy.

Research and Standard Care: Lung Cancer in China

2012 ◽  
pp. 432-436 ◽  
Author(s):  
Tony S. Mok ◽  
Qing Zhou ◽  
Yi-Long Wu
Keyword(s):  
Lung Cancer ◽  
Rural Areas ◽  
Treatment Guidelines ◽  
Tobacco Consumption ◽  
Mutation Status ◽  
Incidence And Mortality ◽  
Governmental Intervention ◽  
Urban And Rural Areas ◽  
Clinical And Translational Research

Overview: China has an enormous burden from rising tobacco consumption and lung cancer incidence. Governmental intervention on lung cancer prevention is insufficient, and both incidence and mortality related to lung cancer are still on the rise. Treatment guidelines are available, but heterogeneity in the quality of care between centers, especially the disparity between urban and rural areas, have resulted in inconsistent care to patients with lung cancer. Despite knowledge on molecular-targeted therapy, only a small fraction of patients have access to routine EGFR mutation analysis. Platinum-based doublet chemotherapy remains the most commonly used regimen irrespective of mutation status. On a positive note, both clinical and translational research on lung cancer are in rapid progress. The Chinese Thoracic Oncology Group (CTONG) has already contributed substantially to the care of patients with lung cancer and is expected to continue in the trend.

scholarly journals Intestinal absorption of epoxy-β-carotenes by humans

1999 ◽  
Vol 339 (2) ◽  
pp. 359-362 ◽  
Author(s):  
Arun B. BARUA
Keyword(s):  
Lung Cancer ◽  
High Risk ◽  
Fruits And Vegetables ◽  
Risk Groups ◽  
Epidemiological Studies ◽  
Protective Effects ◽  
Induction Of Differentiation ◽  
Risk Of Cancer ◽  
Β Carotene ◽  
Reduced Risk

An increased intake of fruits and vegetables has been shown to be associated with reduced risk of cancer. In epidemiological studies, supplements of β-carotene, which is abundant in fruits and vegetables, were not found to be beneficial in reducing the incidence of lung cancer in high-risk groups. Epoxycarotenoids are abundant in nature. 5,6-Epoxy-β-carotene was much more active than β-carotene in the induction of differentiation of NB4 cells [Duitsman, Becker, Barua and Olson (1996) FASEB J. 10, A732]. Epoxycarotenes may, therefore, have protective effects against cancer. In order to do this, however, epoxycarotenoids must be absorbed by the human body. There is no evidence that epoxycarotenoids, despite their abundance in dietary fruits and vegetables, are absorbed by humans. In this paper, it is demonstrated that orally administered dietary or synthetic epoxy-β-carotenes are absorbed by humans, as indicated by their appearance in the circulating blood.

scholarly journals Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Shushan Yan ◽  
Pengjun Zhang ◽  
Wei Xu ◽  
Yuqing Liu ◽  
Bin Wang ◽  
...  
Keyword(s):  
Cancer Incidence ◽  
Meta Analysis ◽  
Positive Association ◽  
Epidemiological Studies ◽  
Protective Role ◽  
Increased Risk ◽  
Incidence And Mortality ◽  
Total Cancer ◽  
Risk Of Cancer

SUA is a potent antioxidant and thus may play a protective role against cancer. Many epidemiological studies have investigated this hypothesis but provided inconsistent and inconclusive findings. We aimed to precisely elucidate the association between SUA levels and cancer by pooling all available publications. Totally, 5 independent studies with 456,053 subjects and 12 with 632,472 subjects were identified after a comprehensive literature screening from PubMed, Embase, and Web of Science. The pooled RRs showed that individuals with high SUA levels were at an increased risk of total cancer incidence (RR=1.03, 95% CI 1.01–1.05,P=0.007). Positive association between high SUA levels and total cancer incidence was observed in males but not females (for men:RR=1.05, 95% CI 1.02–1.08,P=0.002; for women,RR=1.01, 95% CI 0.98–1.04,P=0.512). Besides, high SUA levels were associated with an elevated risk of total cancer mortality (RR=1.17, 95% CI 1.04–1.32,P=0.010), particularly in females (RR=1.25, 95% CI 1.07–1.45,P=0.004). The study suggests that high SUA levels increase the risk of total cancer incidence and mortality. The data do not support the hypothesis of a protective role of SUA in cancer.

ORGAN EQUIVALENT DOSE AND LIFETIME ATTRIBUTABLE RISK OF CANCER INCIDENCE AND MORTALITY ASSOCIATED WITH CARDIAC CT ANGIOGRAPHY

2020 ◽  
Vol 189 (2) ◽  
pp. 213-223
Author(s):  
Seyed Mohammad Bagher Hosseini Nasab ◽  
Mohammad Reza Deevband ◽  
Ali Shabestani-Monfared ◽  
Seyed Ali Hoseini Amoli ◽  
Seyed Hasan Fatehi Feyzabad
Keyword(s):  
Lung Cancer ◽  
Cancer Risk ◽  
Ct Angiography ◽  
Cancer Incidence ◽  
Organ Dose ◽  
Attributable Risk ◽  
Lifetime Attributable Risk ◽  
Incidence And Mortality ◽  
Males And Females ◽  
Risk Of Cancer

Abstract The aim of this study is the calculation of equivalent organ dose and estimation of lifetime attributable risk (LAR) of cancer incidence and mortality related to cardiac computed tomography angiography (CCTA) because the use of CT angiography as a noninvasive diagnostic method has increased. The organ dose has been calculated by ImPACT software based on the volumetric CT dose index (CTDIvol), and LAR of cancer risk incidence and mortality from CCTA has estimated according to the BEIR VII report. The median value of the effective dose was 13.78 ± 6.88 mSv for both genders. In all scanners, the highest median value for LAR of cancer incidence in males and females for lung cancer was 44.20 and 109.17 per 100 000, respectively. And in infants was 5.89 and 12 for lung cancer in males and breast cancer in females, respectively. Also, the median value of LAR of all cancer incidence from single CCTA in adult patients for males and females was 122 and 238 cases, respectively. Maximum LAR of cancer mortality in adults for lung cancer was 40.28 and 91.84 and in pediatrics was 5.69 and 8.50 in males and females, respectively. Despite many benefits of CTA in the heart disease evaluation, according to a high radiation dose in CCTA, to reduce the cancer risk: CCTA should be used cautiously, especially for pediatric and females.

scholarly journals Cancer Incidence and Mortality in 260,000 Nordic Twins With 30,000 Prospective Cancers

2019 ◽  
Vol 22 (2) ◽  
pp. 99-107 ◽  
Author(s):  
Axel Skytthe ◽  
Jennifer R. Harris ◽  
Kamila Czene ◽  
Lorelei Mucci ◽  
Hans-Olov Adami ◽  
...  
Keyword(s):  
General Population ◽  
Cancer Incidence ◽  
Cancer Registries ◽  
Incidence Rates ◽  
Malignant Neoplasms ◽  
Cancer Risk Factors ◽  
Background Population ◽  
Incidence And Mortality ◽  
Risk Of Cancer

AbstractThe Nordic countries have comprehensive, population-based health and medical registries linkable on individually unique personal identity codes, enabling complete long-term follow-up. The aims of this study were to describe the NorTwinCan cohort established in 2010 and assess whether the cancer mortality and incidence rates among Nordic twins are similar to those in the general population. We analyzed approximately 260,000 same-sexed twins in the nationwide twin registers in Denmark, Finland, Norway and Sweden. Cancer incidence was determined using follow-up through the national cancer registries. We estimated standardized incidence (SIR) and mortality (SMR) ratios with 95% confidence intervals (CI) across country, age, period, follow-up time, sex and zygosity. More than 30,000 malignant neoplasms have occurred among the twins through 2010. Mortality rates among twins were slightly lower than in the general population (SMR 0.96; CI 95% [0.95, 0.97]), but this depends on information about zygosity. Twins have slightly lower cancer incidence rates than the general population, with SIRs of 0.97 (95% CI [0.96, 0.99]) in men and 0.96 (95% CI [0.94, 0.97]) in women. Testicular cancer occurs more often among male twins than singletons (SIR 1.15; 95% CI [1.02, 1.30]), while cancers of the kidney (SIR 0.82; 95% CI [0.76, 0.89]), lung (SIR 0.89; 95% CI [0.85, 0.92]) and colon (SIR 0.90; 95% CI [0.87, 0.94]) occur less often in twins than in the background population. Our findings indicate that the risk of cancer among twins is so similar to the general population that cancer risk factors and estimates of heritability derived from the Nordic twin registers are generalizable to the background populations.

scholarly journals Lung Cancer Mortality Trends in a Brazilian City with a Long History of Asbestos Consumption

2019 ◽  
Vol 16 (14) ◽  
pp. 2548 ◽  
Author(s):  
Gisele Aparecida Fernandes ◽  
Eduardo Algranti ◽  
Gleice Margarete de Souza Conceição ◽  
Victor Wünsch Filho ◽  
Tatiana Natasha Toporcov
Keyword(s):  
Lung Cancer ◽  
Cancer Mortality ◽  
Asbestos Exposure ◽  
Lung Cancer Mortality ◽  
Epidemiological Studies ◽  
Sao Paulo ◽  
São Paulo ◽  
Mortality Trends ◽  
Risk Of Death ◽  
Incidence And Mortality

There are scarce epidemiological studies on lung cancer mortality in areas exposed to asbestos in developing countries. We compared the rates and trends in mortality from lung cancer between 1980 and 2016 in a municipality that made extensive use of asbestos, Osasco, with rates from a referent municipality with lower asbestos exposure and with the rates for the State of São Paulo. We retrieved death records for cases of lung cancer (ICD-9 C162) (ICD-10 C33 C34) from 1980 to 2016 in adults aged 60 years and older. The join point regression and age-period-cohort models were fitted to the data. Among men, there was an increasing trend in lung cancer mortality in Osasco of 0.7% (CI: 0.1; 1.3) in contrast to a mean annual decrease for Sorocaba of -1.5% (CI: −2.4; −0.6) and a stable average trend for São Paulo of -0.1 (IC: −0.3; 0.1). Similar increasing trends were seen in women. The age-period-cohort model showed an increase in the risk of death from 1996 in Osasco and a reduction for Sorocaba and São Paulo State during the same period. Our results point to a need for a special monitoring regarding lung cancer incidence and mortality in areas with higher asbestos exposure.

scholarly journals Regional differences in tobacco smoking and lung cancer in Portugal in 2018: a population-based analysis using nationwide incidence and mortality data

BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e038937 ◽  
Author(s):  
Gonçalo Forjaz ◽  
Joana Bastos ◽  
Clara Castro ◽  
Alexandra Mayer ◽  
Anne-Michelle Noone ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Primary Prevention ◽  
Tobacco Smoking ◽  
Population Attributable Fraction ◽  
Tobacco Consumption ◽  
Population Based ◽  
Mortality Data ◽  
Cancer Awareness ◽  
Incidence And Mortality ◽  
Prevention Programmes

ObjectivesThis study aims to estimate the proportion of lung cancer cases and deaths attributable to tobacco smoking in Portugal in 2018, complemented by trends in incidence and mortality, by sex and region.DesignCancer cases for 1998–2011 and cancer deaths for 1991–2018 were obtained from population-based registries and Statistics Portugal, respectively. We projected cases for 2018 and used reported deaths for the same year to estimate, using Peto’s method, the number and proportion of lung cancer cases and deaths caused by tobacco smoking in 2018. We calculated the age-adjusted incidence and mortality rates in each year of diagnosis and death. We fitted a joinpoint regression to the observed data to estimate the annual percentage change (APC) in the rates.SettingPortugal.ResultsIn 2018, an estimated 3859 cases and 3192 deaths from lung cancer were attributable to tobacco smoking in Portugal, with men presenting a population attributable fraction (PAF) of 82.6% (n=3064) for incidence and 84.1% (n=2749) for mortality, while in women those values were 51.0% (n=795) and 42.7% (n=443), respectively. In both sexes and metrics, the Azores were the region with the highest PAF and the Centre with the lowest. During 1998–2011, the APC for incidence ranged from 0.6% to 3.0% in men and 3.6% to 7.9% in women, depending on region, with mortality presenting a similar pattern between sexes.ConclusionExposure to tobacco smoking has accounted for most of the lung cancer cases and deaths estimated in Portugal in 2018. Differential patterns of tobacco consumption across the country, varying implementation of primary prevention programmes and differences in personal cancer awareness may have contributed to the disparities observed. Primary prevention of lung cancer remains a public health priority, particularly among women.

scholarly journals Lung cancer in the Tomsk region (epidemiological aspects)

2019 ◽  
Vol 21 (2) ◽  
pp. 6-9 ◽  
Author(s):  
Evgeny L Choynzonov ◽  
Lilia D Zhuikova ◽  
Olga A Ananina ◽  
Irina N Odintsova ◽  
Lidia V Pikalova
Keyword(s):  
Lung Cancer ◽  
Primary Care Physicians ◽  
National Income ◽  
Risk Groups ◽  
Cancer Center ◽  
Federal State ◽  
Economic Damage ◽  
Incidence And Mortality ◽  
Tomsk Region ◽  
Risk Of Cancer

Aim. To study the incidence and mortality of lung cancer (LC) in the Tomsk region and to assess the economic damage. Materials and methods. The population-based cancer registry data collected at Tomsk Regional Cancer Center and the Federal State Statistics for 2007-2017 were used. The extensive, intensive and standardized variables were analyzed. Results. LC was the 4-th most common cancer, comprising 10.4% (10.1% in the RF) of all cancer cases in the Tomsk region in 2017. It ranked as the first most prevalent cancer for men (17.0%) and the 6-th for women (4.7%). The LC incidence rate decreased by 19.6%, reaching 29.5±1.3 per 100 000 (р=0.0149). It decreased in men (р=0.0006) but was stable in women. In 2017, the lifetime risk of cancer was higher in the Tomsk region than that in the RF, being 7.3% for men and 1.5% for women. LC was the most common cause of mortality from cancer for both sexes (18.9%), being the most common in men (28.1%) and the 4-th most common in women (8.0%). The mortality rate was higher in men than in women (55.6 versus 6.0; р=0.0012). In 2016, the total loss of the life potential in men amounted to 8.4 thousand, for women - 2.5 thousand man-years. Economic damage in the form of conditionally non-produced national income was growing and in 2016 amounted to 263.7 million rubles. Conclusion. Epidemiological analysis of LC in the Tomsk region indicates the relevance of improving the anticancer struggle with the development and implementation of ideas aimed at increasing the cancer literacy of the population and the alertness of primary care physicians, the formation and monitoring of risk groups, the timely routing of patients with suspected cancer.

Cancer risk following alpha-emitter exposure

2018 ◽  
Vol 47 (3-4) ◽  
pp. 115-125
Author(s):  
M. Tirmarche
Keyword(s):  
Lung Cancer ◽  
General Population ◽  
Cancer Risk ◽  
Epidemiological Studies ◽  
Task Group ◽  
Radiological Protection ◽  
Alpha Emitters ◽  
Decay Products ◽  
Alpha Emitter ◽  
Organ Specific

The International Commission on Radiological Protection (ICRP) mandated a task group (Task Group 64) to review recently published epidemiological studies related to cancer risk and incorporated alpha emitters, and to evaluate whether the results might consolidate or challenge assumptions underlying the current radiation protection system. Three major alpha emitters were considered: radon and its decay products, plutonium, and uranium. Results came mainly from cohorts of workers, while for radon, major studies of the general population contributed to a better understanding of the risk of lung cancer at low and chronic exposure. Selection criteria for the review were: assessment of individual exposure of the target organ, long duration of the health survey, availability of attained age at end of follow-up, and adjustment for major co-factors. Task Group 64 is composed of members from ICRP Committees 1 and 2 (because epidemiological and dosimetric expertise were needed) and external experts. A first report (ICRP Publication 115) considered the risk of lung cancer related to inhalation of radon and its decay products. As the estimated excess risk per unit of exposure was higher by a factor of 2 compared with a previous ICRP estimate in 1993, Task Group 64 suggested a reconsideration of the reference levels for the workplace and for the general population. A second report, using the same standardised methodology (lung cancer baselines, population, life expectancy), will include estimation of the cancer risk of nuclear workers exposed to plutonium, focusing on the risk of lung cancer. A comparison of these risks with those of populations exposed to external gamma radiation alone will be made in the near future. For uranium, the results related to the organ-specific dose were too sparse to draw reliable conclusions, despite a recent publication. More research is needed on this topic.

Sign in / Sign up

Export Citation Format

Share Document